Site map – Europlasma Group
Pages
Categories
News
Number of shares and voting rights as at 31/12/2020
Inertam treated 2,300 tonnes of waste along the second half of 2020
Europlasma’s deleveraging : issue of 650 convertible bonds for the benefit of Global Tech Opportunities 1 Fund
Group’s deleveraging validated by the Extraordinary General Meeting of shareholders on 28/12/2020
Debt restructuring agreement of CHO Morcenx validated by the Mont de Marsan’s Commercial Court
Information relative to the Extraordinary General Meeting of shareholders on 28/12/2020
Extraordinary General Meeting of shareholders on 28/12/2020 behind closed doors
Drawdown of the tranche 13 of 200 convertible notes
Number of shares and voting rights as at 30/11/2020
Extraordinary General Meeting of shareholders convened on 28/12/2020 behind closed doors
Strategic reorientation of the CHO Morcenx site
Restructuring of CHO Morcenx’s debt allowing a massive deleveraging of the Group
Number of shares and voting rights as at 31/10/2020
Drawdown of the tranche 12 of 200 convertible notes
Hugo Brugière resigns from his mandate as director
Postponement of the extraordinary General Meeting of shareholders convened on 28/10/2020
Anil Bhat appointed as Group’s Chief Commercial Officer
2020 Half-Year Results
Extraordinary General Meeting of shareholders convened on 28/10/2020
Number of shares and voting rights as at 30/09/2020
Ordinary and extraordinary General Meeting of shareholders on 22/09/2020
Official restart ceremony of Inertam’s plant
Agreement with Hangzhou University in China
Inertam’s newsletter
Number of shares and voting rights as at 31/08/2020
Ordinary and extraordinary General Meeting of shareholders on 31/08/2020 – Provisional quorum
Ordinary and extraordinary General Meeting of shareholders on 31/08/2020 – Provisional quorum
Successful restart of the Inertam plant : well done and thank you
Call to the ordinary and extraordinary General Meeting of shareholders on 31/08/2020
Number of shares and voting rights as at 31/07/2020
Drawdown of the tranche 11 of 200 convertible notes
Drawdown of the tranche 10 of 200 convertible notes
EUROPLASMA accelerates the pace of its financing to support its development strategy
Europlasma wants to clean up oil industry
GRTgaz selects EUROPLASMA
Drawdown of the tranche 8 of 200 convertible notes
Number of shares and voting rights as at 30/06/2020
The National Assembly chooses Europlasma for the treatment of asbestos
Heating of the Inertam asbestos waste treatment plant
Inertam’s newsletter
Restart of Inertam, a new major step in the strategic plan
Number of shares and voting rights as at 31/05/2020
BFM Interview – Jérôme Garnache Group’s C.E.O.
Technical information on Europlasma’s shares consolidation
Europlasma’s share consolidation
Europlasma increases its anchoring in China
Number of shares and voting rights as at 30/04/2020
Publication of the FY2019 Annual Financial report
Drawdown of the tranche 7 of convertible bonds
Drawdown of the 7th tranche of 200 convertible bonds
Extraordinary Shareholders’ Meeting of April 27, 2020
FY2019 Annual Results
Extraordinary Shareholders’ Meeting of April 27, 2020 behind closed doors
Inertam’s newsletter
Number of shares and voting rights as at 31/03/2020
Extraordinary Shareholders’ Meeting of April 6, 2020
Extraordinary Shareholders’ Meeting of April 6, 2020 behind closed doors
Invitation to the Extraordinary Shareholders’ Meeting of April 6, 2020
Number of shares and voting rights as at 29/02/2020
Inertam’s Newsletter
Consolidation of shares planned and equity financing secured
Inertam’s newsletter
Number of shares and voting rights as at 31/01/2020
2019 half-year results
Inertam’s newsletter
Number of shares and voting rights as at 31/12/2019
Letter of intent for the final treatment of fly ash for 4 waste incinerators in China
Ordinary General Meeting of Shareholders holds on 20 Dec. 2019
Cooperation agreement with the city of LaiXi for the deployment of the Group’s technologies in China
Number of shares and voting rights as at 30/11/2019
Inertam’s newsletter
Ordinary Shareholders’ Meeting of November 29, 2019
Europlasma presents its strategic orientation
Strengthened Management team and new organisation finalized
Invitation to the Ordinary Shareholders’ Meeting of November 29, 2019
Inertam Newsletter
Number of shares and voting rights as at 31/10/2019
Europlasma confirms the renewal of its eligibility for French PEA-PME device
2018 Annual Results of the Group
Drawdown of the second tranche of 200 convertible bonds
Update on Group’s activity
Number of shares and voting rights as at 30/09/2019
Inertam Newsletter
A framework partnership agreement with Orano Cycle has come into effect
Drawdown of the first tranche of 200 convertible bonds
Number of shares and voting rights as at 31/08/2019
ISSUANCE OF 3,000 WARRANTS GIVING ACCESS TO NOTES CONVERTIBLE INTO SHARES WITH SHARE SUBSCRIPTION WARRANTS ATTACHED
General meeting of Shareholders on 3 September 2019
General meeting of Shareholders on 20 August 2019
Update on the Group’s activity
Number of shares and voting rights as at 31/07/2019
Business continuity plans adopted by the Commercial Court
General Management strengthened: Olivier Pla appointed as Deputy Chief Executive Officer of the Group
Invitation to the Ordinary and Extraordinary Shareholders’ Meeting of August 20, 2019
Date of deliberations of the Commercial Court extended to August 2, 2019
Conversion of convertible bonds by Zigi Capital
18/07/2019 Commercial Court session: deliberation end of July
Number of shares and voting rights as at 30/06/2019
First measures to enable to set up the continuation plan
Number of shares and voting rights as at 31/05/2019
Observation period maintained
Update on legal proceedings progress
Number of shares and voting rights as at 30/04/2019
Update on legal proceedings progress
Update on legal proceedings progress
Details concerning BSAR exercise
Number of shares and voting rights as at 31/03/2019
Legal proceedings update
Europlasma shares trading is suspended pending a press release
Number of shares and voting rights as at 28/02/2019
Termination of the liquidity contract
Number of shares and voting rights as at 31/01/2019
Group’s update
Europlasma shares trading is suspended pending a press release
Call to a General Meeting of Shareholders
Invitation to General Meeting of Shareholders
Number of shares and voting rights as at 31/12/2018
Half-year report on liquidity contract as at 31/12/2018
Update on funding prospects
Number of shares and voting rights as at 30/11/2018
Participation in Pollutec exhibition
Suspension of the automatic issuance of the 4th warrant given access to convertible bonds
ADEME published IGAR applicant sheet
Number of shares and voting rights as at 31/10/2018
Half-year consolidated Resultats as at 30/06/2018
Europlasma announces the reactivation of the financing agreement by issuance of convertible bonds
International Solid Waste Management Summit
Number of shares and voting rights as at 30/09/2018
General Meeting of Shareholders on 27 September 2018
Inertam exhibits at “Salon des Professionnels de l’amiante”
Europlasma is present at Shanghai
Europlasma announces the signature of a partnership framework agreement with Orano Cycle and the progress of discussions with financial investors to have a reference shareholder
1st “Assises Nationales de la pyrogazéification” on 26 & 27 Sept. 2018
Number of shares and voting rights as at 31/08/2018
Suspension of the automatic issuance of the 3rd warrant given access to convertible bonds
Number of shares and voting rights as at 31/07/2018
Update on the Group’s commercial activity
Renewal of the convertible bonds financing contract
Number of shares and voting rights as at 30/06/2018
Half-year report on liquidity contract as at 30/06/2018
General meeting of Shareholders, new call
Renewal eligibility for the French PEA-PME regime
Update on the Group’s activity
General Meeting, new call
Number of shares and voting rights as at 31/05/2018
Number of shares and voting rights as at 30/04/2018
Availability of the 2017 Registration Document
2017 Annual Results of the Group
Europlasma announces an agreement with European High Growth Opportunities Securitization Fund improving the conditions of the 3rd tranche of convertible bonds
EIB and Europlasma announce the signature of a € 30 million financing contract for the innovative CHO Tiper project
Europlasma announces a capital increase in its subsidiary CHO Power, valuing it at €101 million, and a simultaneous reorganisation of CHO Morcenx
Number of shares and voting rights as at 28/02/2018
Europlasma commits alongside Arcelor Mittal to reducing the carbon footprint of the steel industry
Convertible bonds financing contract for a maximum amount of EUR 8 million
Number of shares and voting rights as at 31/01/2018
Half-year report on liquidity contract as at 31/12/2017
Number of shares and voting rights as at 30/12/2017
The European Investment Bank intends to support the CHO Tiper project by providing up to 30 million euro of debt financing
The European Investment Bank intends to support the CHO Tiper project by providing up to 30 million euro of debt financing
Number of shares and voting rights as at 30/11/2017
Information relative to BSAR C
Number of shares and voting rights as at 31/10/2017
Free allocation of stock warrants
General Meeting of shareholders on 26/10/2017
2017 half-year Results as at 30 June 2017
General Meeting of Shareholders, new call
Number of shares and voting rights as at 30/09/2017
ERRATUM
Review of the 2014-2017 Strategy and growth outlook
Asbestos Professional Exhibition – Regional Appointment, Nantes 16 november 2017
Contamination Expo Event– Excel London 27&28 september 2017
Asbestos Professional Exhibition – Paris La Villette 13 & 14 september 2017
Press release
Press release
Debt reduction: capital increase by conversion of debts
Number of shares and voting rights as at 31/07/2017
Issuance of the last tranche of OCABSA
Delivery of the vitrification unit for fly ash in China
Half-year report on liquidity contract as at 30/06/2017
Information on number of shares and voting rights
Issuance of OCABSA Tranche 13
General Meeting of Shareholders on 29 June 2017
Annual General Meeting of Shareholders, second call
